COMMUNIQUÉS West-GlobeNewswire

Curia Unveils Brand Refresh at CPHI WW in Milan

07/10/2024 - 15:49

The refined brand highlights Curia’s key capabilities and personalized approach across small molecules, generic APIs and biologics ALBANY, N.Y., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, [...]

Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile

07/10/2024 - 15:52

Affiliates of Murchinson, 3i LP, and existing senior debt holder, Oramed Pharmaceuticals, Inc. (“Oramed”), are expected to participate in the $50 million convertible note offering, which is expected to close on or about [...]

Le Roulons pour vaincre le diabète FRDJ rassemble les entreprises canadiennes pour pédaler vers la guérison du diabète de type 1

07/10/2024 - 16:00

TORONTO, 07 oct. 2024 (GLOBE NEWSWIRE) -- L'un des événements de collecte de fonds les plus anciens et les plus importants du Canada aura lieu à Montréal (Québec) et à Toronto (Ontario) les 10 et 17 octobre [...]

The JDRF Ride to Defeat Diabetes brings corporate Canada together to pedal for a cure for type 1 diabetes

07/10/2024 - 16:00

TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- One of Canada’s longest running and top fundraising events will be taking place in Montréal, QC and Toronto, ON on October 10 and 17 respectively. The JDRF Ride to Defeat [...]

Colateral completes acquisition of Turbyne creating the first retail media operating system designed for in-store, that integrates with all channels and partners

07/10/2024 - 17:00

TRURO, United Kingdom, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Colateral , a retail marketing platform, announced today the acquisition of Turbyne, a Delaware-based provider of omnichannel Retail Media capabilities, in a [...]

CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques

07/10/2024 - 17:05

Abstract to be presented at the 5 th annual HIV Research for Prevention Conference Study results highlight potential for treatment VANCOUVER, Washington, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (" [...]

Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024

07/10/2024 - 17:05

Precision Neuroscience’s Cortical Surface Array unlocks an unprecedented view of neural patterns, poised to revolutionize neural decoding NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Researchers shared groundbreaking [...]

Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions

07/10/2024 - 18:00

Safe Group et SpineUp au NASS 2024 : des synergies pour accélérer le déploiement des solutions Fleurieux-sur-l’Arbresle - France - le 7 octobre 2024 à 18h . Safe SA (FR001400F1V2 – ALSAF), spécialiste dans la conception [...]

EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation

07/10/2024 - 18:00

Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]

EssilorLuxottica: Third-Quarter 2024 Revenue Conference Call Invitation

07/10/2024 - 18:00

Third-Quarter 2024 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Third-Quarter 2024 Revenue [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

07/10/2024 - 19:00

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

07/10/2024 - 19:00

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

07/10/2024 - 19:00

Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 7 octobre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y’s, Inc.

07/10/2024 - 22:00

TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”) is pleased to announce that it is capitalizing on its extensive experience operating wellness [...]

Simtra BioPharma Solutions Expands Capabilities with $14M Investment in ADC Conjugation and Purification Clinical Suite

07/10/2024 - 22:00

Enhancing End-to-End Service Offering for Accelerated Development and Manufacturing of Antibody-Drug Conjugates (ADCs) as part of the scaling of its Development Services Business PARSIPPANY, N.J., Oct. 07, 2024 (GLOBE [...]

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

07/10/2024 - 22:01

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation PARIS, France, October 7, 2024, 10:00 p.m. CEST – Abivax SA ( [...]

Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

07/10/2024 - 22:01

Company advancing BDTX-1535 in EGFRm NSCLC towards key inflection points in Q1 2025 Will deprioritize BDTX-4933 and seek potential partners Anticipated cost savings expected to extend cash runway into Q2 2026 CAMBRIDGE [...]

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

07/10/2024 - 22:04

A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate Cancer Represents Potential Paradigm Shift in How Urologists Might [...]

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

07/10/2024 - 22:05

FOSTER CITY, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]